In an article published in Thomson Reuters, Alex Malyshev and Sarah Ganley of the firm’s Cannabis, Hemp & CBD Industry Group discuss the risks that arise as states legalize cannabis and expand programs while a federal prohibition remains in place. This is the first column in a regular series to be published by Alex and other members of the Industry Group.
